Candelanza, Mary Joy M.
HRN: 19-41-50 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/17/2025
CEFTRIAXONE 1G (VIAL)
09/17/2025
09/24/2025
IVT
2g
OD
CAP MR
Checking Initial Appropriateness
09/17/2025
AZITHROMYCIN 500MG TABLET (TAB)
09/17/2025
09/22/2025
ORAL
500mg
OD
CAP MR
Checking Initial Appropriateness
09/26/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/26/2025
10/03/2025
IVTT
4.5g
Q6H
CAP-MR
Checking Initial Appropriateness